Blog
About

9
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Resistive breathing (RB), a hallmark of obstructive airway diseases, is characterized by strenuous contractions of the inspiratory muscles that impose increased mechanical stress on the lung. RB is shown to induce pulmonary inflammation in previous healthy animals. Tiotropium bromide, an anticholinergic bronchodilator, is also shown to exert anti-inflammatory effects. The effect of tiotropium on RB-induced pulmonary inflammation is unknown.

          Methods

          Adult rats were anesthetized, tracheostomized and breathed spontaneously through a two-way non-rebreathing valve. Resistances were connected to the inspiratory and/or expiratory port, to produce inspiratory resistive breathing (IRB) of 40% or 50% P i/ P i,max (40% and 50% IRB), expiratory resistive breathing (ERB) of 60% P e/ P e,max (60% ERB) or combined resistive breathing (CRB) of both 40% P i/ P i,max and 60% P e/ P e,max (40%/60% CRB). Tiotropium aerosol was inhaled prior to RB. After 6 h of RB, mechanical parameters of the respiratory system were measured and bronchoalveolar lavage (BAL) was performed. IL-1β and IL-6 protein levels were measured in lung tissue. Lung injury was estimated histologically.

          Results

          In all, 40% and 50% IRB increased macrophage and neutrophil counts in BAL and raised IL-1β and IL-6 lung levels, tissue elasticity, BAL total protein levels and lung injury score. Tiotropium attenuated BAL neutrophil number, IL-1β, IL-6 levels and lung injury score increase at both 40% and 50% IRB. The increase in macrophage count and protein in BAL was only reversed at 40% IRB, while tissue elasticity was not affected. In all, 60% ERB raised BAL neutrophil count and total protein and reduced macrophage count. IL-1β and IL-6 levels and lung injury score were increased. Tiotropium attenuated these alterations, except for the decrease in macrophage count and the increase in total protein level. In all, 40%/60% CRB increased macrophage and neutrophil count in BAL, IL-1β and IL-6 levels, tissue elasticity, total protein in BAL and histological injury score. Tiotropium attenuated the aforementioned alterations.

          Conclusion

          Tiotropium inhalation attenuates RB-induced pulmonary inflammation.

          Related collections

          Most cited references 29

          • Record: found
          • Abstract: found
          • Article: not found

          Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis.

          Clinical cluster analysis from the Severe Asthma Research Program (SARP) identified 5 asthma subphenotypes that represent the severity spectrum of early-onset allergic asthma, late-onset severe asthma, and severe asthma with chronic obstructive pulmonary disease characteristics. Analysis of induced sputum from a subset of SARP subjects showed 4 sputum inflammatory cellular patterns. Subjects with concurrent increases in eosinophil (≥2%) and neutrophil (≥40%) percentages had characteristics of very severe asthma.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Neural reflexes in inflammation and immunity

            The 1908 Nobel Prize in Physiology or Medicine was shared by Ilya Mechnikov and Paul Ehrlich for identifying the cellular and humoral basis of immunity. Although this represented a landmark celebration of two giants in the nascent immunology field, the shared prize also stoked the ongoing controversy over which of their two theories primarily accounted for protective immunity. During this same period, another fledgling scientific field was entangled in a different, but equally raging intellectual debate. Neuroscientists, freshly armed with the ability to visualize neurons using the staining methods of Cajal and further endowed with new concepts of “synapses” and the motor cortex elucidated by Charles Sherrington, argued whether the fundamental unit of information transfer between neurons was electrical or chemical. The answer came in 1921 when Otto Loewi placed two beating frog hearts in separate saline baths: one heart he left attached to its vagus nerve and the other he denervated. After observing that electrically stimulating the intact vagus nerve slowed the innervated heart, he then harvested saline from this bath, and transferred it to the denervated system. Reporting that a substance in the conditioned media caused the denervated heart to slow, Loewi named the transferable agent “Vagusstoff.” Henry Dale, who later shared the Nobel Prize with Loewi, identified the active agent as acetylcholine, which he isolated from ox and horse spleens (Dale and Dudley, 1929). From that point forward, immunology and neuroscience progressed on parallel paths. Physiologists came to understand that neural circuits, operating reflexively, controlled the function of the cardiovascular, gastrointestinal, and musculoskeletal systems, but there was considerable resistance to extending these mechanisms to immune system homeostasis. Immunity was viewed as autonomous to the immune system, mediated by interactions between immune cells in a largely self-regulated system that could be influenced by external factors, humoral mediators, and products of immunocompetent cells. Until very recently, neither field paid much notice to direct evidence that the immune system is functionally and anatomically connected to the nervous system. The origin of meaningful collaborations between these fields perhaps began with the identification of the antiinflammatory action of neuroendocrine hormones. Early animal studies established that adrenal hormones, produced under the regulation of the hypothalamic pituitary axis and adrenocorticotropic hormone, possessed activities that could be placed into two categories. One influenced fluid homeostasis, and the other exerted beneficial effects against shock and rheumatoid arthritis. Clinical studies demonstrating the therapeutic effectiveness of corticosteroids in rheumatoid arthritis won Philip Hench the Nobel Prize in 1950. This catalyzed investigation into mechanisms by which hormones and other soluble mediators normally balance the immune system. Work dating back to 1961 demonstrated that electrically stimulating the vagus nerve significantly enhanced the release of acetylcholine from the spleen (Brandon and Rand, 1961; Leaders and Dayrit, 1965). By then, anatomy studies had already revealed the innervation of the spleen, thymus, lymph nodes, and even the bursa of Fabricus. Later advances in electron microscopy and immunohistochemistry, when used to image the principle organs of the immune system, revealed nerve endings in the vicinity of T cells, B cells, and macrophages. The origin of these neurons was traced to nuclei residing in the brain stem, the sympathetic chain, and peripheral ganglion cells. Synapse-like structures formed by nerve endings were found lying within mere nanometers of immune cells that express receptors for acetylcholine, catecholamines, neuropeptides, and other principle neurotransmitters. These incipient neural circuits attracted little notice from the broader field of neuroscience, perhaps because it was not known whether information transfer from the nervous system could meaningfully regulate immune responses or how this communication could be studied. Immunologists also took little notice, perhaps because of the prevailing view that the immune system is autonomous, and that immunity could be fully understood by studying the activities and interactions between its principle cells. Neuroscience and immunology directly intersected in the 1990s, when Linda Watkins made the seminal discovery that fever in rodents after intraabdominally administered IL-1β required an intact vagus nerve (Watkins et al., 1995a). This meant that action potentials transmitted in sensory nerve fibers to the brainstem report the presence of inflammatory substrates in peripheral tissues. Using sensitive neurophysiological techniques to record nerve fiber activity, Niijima traced the path of action potentials traveling in the vagus nerve from the liver to the brainstem, and showed that these signals activated descending neurotransmission to the spleen, thymus, and other organs (Niijima et al., 1991, 1995, Niijima et al., 1996). This new paradigm established an essential early role for the sensory nervous system in a fundamental mechanism of host defense. At about this time, we were working with colleagues to understand how a tetravalent guanylhydrazone (CNI1493) significantly blocked cytokine release and attenuated disease in arthritis and other animal models (Bianchi et al., 1996). We surreptitiously observed that an intact vagus nerve was required for CNI1493 to effectively inhibit cytokine release in vivo ( Borovikova et al., 2000a ). To determine the underlying mechanisms, we electrically stimulated the vagus nerve, and showed that driving action potentials into the reticuloendothelial organs significantly inhibited cytokine production (Borovikova et al., 2000b). Considering these findings together with Watkins and Niijima’s observations, we proposed that afferent and efferent signals transmitted in the vagus nerve are components of an inflammatory reflex, a neural circuit that modulates innate immune responses (Tracey, 2002). This became the founding, prototypical member of an expanding family of reflex neural circuits that maintain immunological homeostasis. These neural mechanisms are essential to understanding immunity. In the remainder of this review, we discuss illustrative examples of neural circuits that modulate immune responses. The discussion is not encyclopedic, but instead focuses on prototypical neural circuits that interact with immune cells to maintain stable physiological responses and immunological homeostasis. We also discuss recent advances in understanding how neural and immunological information merge. Immunological homeostasis and nonresolving inflammation The functional operation of organ systems is maintained within a narrow, optimal range, largely under the control of neural circuits that operate reflexively to adjust organ function relative to an established set point. Reflexes fine-tune the functional output of the cardiovascular, gastrointestinal, respiratory, renal, musculoskeletal, and neuroendocrine systems in response to alterations in the external and internal environment. “Immunological homeostasis” is also essential for health, because insufficient or excessive activity in the immune system causes disease (Tracey, 2007). During sterile injury, ischemia, or infection, the activation of humoral and cellular immune responses protects against invasion, cleans up the detritus of tissue injury, and initiates wound healing and repair mechanisms. These responses are normally short-lived, and the resolution of inflammation is an essential component of immunological homeostasis. Abundant evidence indicates that nonresolution of inflammation drives the pathogenesis of sepsis, atherosclerosis, obesity, cancer, pulmonary disease, inflammatory bowel disease, neurodegeneration, multiple sclerosis, and rheumatoid arthritis (Nathan and Ding, 2010). Humoral, cellular, and neural mechanisms prevent nonresolving inflammation (Fig. 1; Nathan and Ding, 2010). Humoral, or soluble, antiinflammatory mediators have been studied since the discovery of the antiinflammatory properties of corticosteroids. Deficiencies in glucocorticoids or the pituitary hormones that normally regulate their production confer exquisite sensitivity to inflammation and infection (Besedovsky and del Rey, 2000; Sternberg, 2006). Glucocorticoid levels rise early with the onset of inflammation or stress, providing important feedback signals to suppress immune responsiveness and protect the host from the toxicity and tissue injury caused by excessive inflammation. The discovery of macrophage-derived TGF-β as an antiinflammatory mediator that deactivates macrophages opened a new field focused on soluble negative feedback mediators produced by the immune system. (Tsunawaki et al., 1988). IL-10 was later implicated as another prototypical inflammation-resolving humoral mediator produced by monocytes (Mosser and Zhang, 2008). The growing list of antiinflammatory mediators includes soluble cytokine receptors, cytokine receptor antagonists, eicosanoids, and oxygenated and nitrated lipids (Nathan, 2002). Figure 1. Humoral, cellular, and neural regulation of nonresolving inflammation. Nonresolving inflammation mediates the pathogenesis of many major diseases. Understanding mechanisms that reverse or prevent nonresolving inflammation has important implications for the development of therapeutics. Humoral and cellular antiinflammatory mechanisms are perhaps the most widely studied, and are covered in detail in other reviews. As reviewed here, recent advances in neuroscience and immunology have identified neural circuits that modulate the immune system. Understanding these circuits will reveal mechanisms for the localized and rapid control of immunity with significant therapeutic implications. Cellular mechanisms also prevent nonresolving inflammation. For example, proinflammatory phagocytes switch to an antiinflammatory phenotype that promotes tissue repair rather than tissue destruction (Nathan and Ding, 2010). TGF-β and IL-4 stimulate macrophages to assume an alternatively activated antiinflammatory phenotype (Nathan, 2002; Mosser and Zhang, 2008). Regulatory T cells and myeloid-derived suppressor cells also limit inflammation. The nervous system, which receives information from the immune system in the form of soluble mediators and from sensory neurons, also suppresses inflammation (Watkins et al., 1995b; Tracey, 2007). Immune system molecules can cross the blood–brain barrier by exploiting specific saturable transport mechanisms, by transcytosis across brain endothelial cells, or by entering the brain in regions that are devoid of a blood–brain barrier. Inflammatory cells can also cross the blood–brain barrier. The binding of soluble immune signaling molecules to cognate receptors expressed on central nervous system (CNS) neurons, astrocytes, and microglial cells produces cellular responses that change the activity of neural circuits in brain stem and in hypothalamic nuclei, which control the autonomic nervous system and the neuroendocrine system. As in the aforementioned case of IL-1–mediated fever, afferent information can also arrive in the CNS from peripheral sensory neurons that are activated by immune mediators (Watkins et al., 1995a,b). Sensory neurons propagate action potentials to the brain stem nucleus tractus solatarius and other nuclei that receive afferent information. Afferent neurons express receptors for TNF, IL-1, LPS, and other products of inflammation. Incoming information from the immune system activates neural reflex circuits that underlie the behavioral and physiological responses associated with acute and chronic immune responses, including acute phase protein responses, fever, anorexia, insulin resistance, chronic sickness behavior, depression, and cachexia (Watkins et al., 1995b). Sensory neurons propagate information very quickly, and from discrete anatomical regions. These communication features enable the CNS to rapidly localize incoming information and transmit outgoing instructions to other organ systems. This is not possible with immune signals sent in the form of diffuse humoral factors. It is helpful to remember that neurotransmission is ideally suited to correctively modulate system functions that deviate acutely from physiological set points. Humoral neuroendocrine mechanisms occupy more important roles in establishing and maintaining chronic set point responses. The autonomic nervous system primarily regulates organ homeostasis via reflexes that are comprised of afferent and efferent neurons. Specialized afferent neurons initiate the reflex by responding to changes in the environment. Action potentials can be initiated in sensory neurons in response to changes in cytokine levels, pH, oxygen tension, and other molecular and chemical changes in the milieu. Afferent signals travel to the CNS along the vagus, splanchnic, and pelvic nerves; autonomic pain fibers originating in blood vessels may travel with somatic nerves. The efferent or outgoing arc of the basic reflex circuit is comprised of nerve fibers that travel to the organs and use acetylcholine and norepinephrine as principle neurotransmitters. Physiologists, pharmacologists, and anatomists usually characterize autonomic reflexes as either “sympathetic” or “parasympathetic,” but this functional nomenclature is imprecise. Henry Dale, one of fathers of neuroscience, argued strongly against the use of functional monikers to describe neural circuits (Dale, 1954). He called for the labeling of neural circuits by virtue of their neurotransmitters (adrenergic or cholinergic) rather than their function (sympathetic or parasympathetic). Indeed, the limitations are apparent in characterizing the neural circuits that regulate immunity, as they have components that are cholinergic, adrenergic, and peptidergic, and involve T cells and endothelial cells that are neurally controlled to secrete neurotransmitters that ultimately target macrophages and lymphocytes to alter expression of cytokines and cell surface proteins (Andersson and Tracey, 2012). It is not possible to neatly classify these as sympathetic or parasympathetic. Neural circuits regulate immunity in Caenorhabditis elegans Direct evidence of neurons regulating immune responses can be found in the nematode worm, C. elegans, an evolutionarily ancient animal that feeds on soil bacteria and is endowed with primitive immune and nervous systems. Physiological homeostasis and motor behavior is regulated by some 302 neurons and 56 glial cells that coordinate the response to the internal and external environment. The animal’s nervous system utilizes signaling molecules closely related to mammalian counterparts including TGF-β, insulin, and the neurotransmitters acetylcholine, γ-aminobutyric acid, and norepinephrine. This early nervous system is sufficient to exert significant control over the activity of the innate immune response to infection (Aballay, 2009; Sun et al., 2011; Tracey, 2011). Neural circuits have therefore coevolved with, and influenced, the evolution of immunity, at least as far back as the invertebrate period. Inflammatory reflex In the inflammatory reflex (Fig. 2), a prototypical neural circuit, exogenous and endogenous molecular products of inflammation activate afferent action potentials traveling in the vagus nerve to the nucleus tractus solatarius, which relays the neuronal signals to other brain nuclei located in the hypothalamus and brainstem (Watkins et al., 1995a, 1999; Niijima, 1996; Goehler et al., 1997). Efferent signals travel from the nucleus ambiguus and dorsal motor nucleus back down the vagus nerve, which terminates in the celiac ganglia (Berthoud and Powley, 1996; Borovikova et al., 2000b). Stimulation of the vagus nerve activates adrenergic splenic neurons residing in the celiac ganglion, which travel into the spleen and terminate in synapse-like structures adjacent to T cells in the white pulp (Rosas-Ballina et al., 2011). Norepinephrine released from splenic neurons binds to β2 adrenergic receptor expressed on a subset of T cells that expresses choline acetyltransferase, the rate-limiting enzyme in acetylcholine biosynthesis. Figure 2. The inflammatory reflex. The prototypical reflex circuit regulating immunity is comprised of afferent and efferent signals transmitted in the vagus nerve in response to the molecular products of infection and injury, including cytokines, eicosanoids, DAMPs, and PAMPs. The activation of adrenergic neurons in the spleen culminates in the release of norepinephrine in the vicinity of T cells that are capable of secreting acetylcholine. Acetylcholine crosses the marginal zone and enters the red pulp, where it interacts with α7 nAChR expressed on cytokine producing macrophages. α7 nAChR signal transduction suppresses the synthesis and release of TNF, IL-1, IL-18, HMGB1, and other cytokines. The inflammatory reflex is impaired in nude mice, meaning that vagus nerve stimulation fails to inhibit cytokine release in the absence of T cells (Rosas-Ballina et al., 2011). Strikingly, the passive transfer of T cells expressing choline acetyltransferase, which produce acetylcholine, significantly restores the inflammatory reflex in nude mice. Thus, T cells provide the acetylcholine that acts as the terminal neurotransmitter to complete the inflammatory reflex circuit. Splenic nerve endings in the splenic white pulp form synapse-like structures with T cells that express β2 adrenergic receptors and respond to norepinephrine (Felten and Olschowka, 1987; Rosas-Ballina et al., 2011). These acetylcholine-synthesizing T cells, which express a CD4+CD44hiCD62Llo surface phenotype, represent <3% of the total T cell population and 10% of the total memory T cell population. They produce IL-17A, IL-10, and IFN-γ, but not IL-4 or IL-6, after stimulation with plate-bound anti-CD3. T cell stimulation significantly enhances the capacity of these cells to produce acetylcholine. Acetylcholine-producing T cells are also found in lymph nodes and Peyer’s patches (Rosas-Ballina et al., 2011). The origins and fate of these cells during development and the response to injury and infection is currently being studied. Acetylcholine released by these splenic T cells binds to α7 nAChR expressed on macrophages in the red pulp and marginal zone (Rosas-Ballina et al., 2011). In macrophages, α7 nAChR signals down-regulate cytokine synthesis by suppressing nuclear translocation of NF-κB (Wang et al., 2003, 2004). α7 nAChR-deficient mice are exquisitely sensitive to nonresolving inflammation induced by endotoxemia or adjuvant arthritis (Wang et al., 2003; van Maanen et al., 2010). However, the inflammatory reflex in these mice is significantly restored by passive transfer of WT bone marrow, indicating that that bone marrow–derived cells, and not neurons (which can also express α7 nAChR), are required for the integrity of the inflammation-resolving circuit (Olofsson et al., 2012). Anatomical, functional, and molecular lesions in the vagus nerve enhance cytokine production associated with nonresolving inflammation (Tracey, 2007). Under basal conditions, the vagus nerve transmits tonic inhibitory activity that dampens the activity of the innate immune response to pathogen associated molecular products (Rosas-Ballina et al., 2009). The inhibitory activity of the inflammatory reflex can be enhanced by methods that increase the generation of adrenergic signals in the splenic nerve. This has been accomplished experimentally by electrically stimulating the vagus nerve, by electrically stimulating the splenic nerve directly, or by pharmacologically activating the adrenergic splenic neurons using cholinergic agonists (Borovikova et al., 2000b; Bernik et al., 2002; Wang et al., 2003,2004; Metz and Tracey, 2005; Vida et al., 2011) The activity of the splenic adrenergic neurons can be functionally modified by either preganglionic neurons arising on the sympathetic chain, or by signals arriving there from the vagus nerve that terminate on interneurons residing in the celiac ganglion that can modulate the signals arising from the sympathetic chain. Detailed functional mapping of this pathway has also been aided by studies in which the vagus nerve was transected and electrical stimulation was applied to the distal segment. This efferent signal significantly enhances spleen norepinephrine and acetylcholine release, and suppresses cytokine production (Borovikova et al., 2000b; Bernik et al., 2002; Vida et al., 2011). Moreover, after vagus nerve transection, the adrenergic splenic nerve can also be activated by cholinergic agonists that target the celiac ganglion. In addition, adrenergic neurons in the spleen are modified by the onset of inflammation (Straub et al., 2008). Splenic neurons degenerate during the onset of adjuvant arthritis in rodents, and maximal loss of splenic neurons occurrs just before the onset of maximal inflammation. The functional outcome of this denervation is an absence of the tonic inhibitory influence of the inflammatory reflex and an exacerbation of inflammatory responses similar to that seen after transection or chemical ablation of the splenic nerve (van Maanen et al., 2009a,b, 2010). Experimental tools that have been used to map these neural circuits to the immune system include electrodes, which directly stimulate the neural components of the inflammatory reflex (vagus and splenic nerves), pharmacological agonists that target α7 nAChR to deactivate macrophages, and pharmacological agonists that target muscarinic acetylcholine (M1) receptors in the brain to up-regulate efferent vagus nerve activity (Pavlov et al., 2006, 2009). CNI-1493 is an M1 agonist, a fact that explains the original unexpected discovery that CNI-1493 activated the vagus nerve to suppress inflammation in vivo (Bianchi et al., 1996; Borovikova et al., 2000a). M1 brain cholinergic networks can also be activated by administration of ghrelin, oxytocin, or centrally acting acetylcholinesterases. Each of these agents significantly stimulates vagus nerve signaling and reduces cytokine release. Patients with autoimmune disease and nonresolving inflammation develop significantly impaired vagus nerve signaling, which accelerates the progression of inflammation and prevents resolution (Tracey, 2007). Vagus nerve signaling to the spleen “reprograms” leukocytes and attenuates their migration to joints affected with synovitis (Saeed et al., 2005). Studies of collagen-induced arthritis in α7 nAChR-deficient mice confirm that synovial inflammation is markedly increased compared with WT controls (van Maanen et al., 2009a,b). Furthermore, in WT mice with collagen-induced arthritis, treating with α7 nAChR agonists or electrical vagus nerve stimulation significantly ameliorates arthritis activity and tissue destruction. The measurement of deficient basal levels of vagus nerve activity in human disease has become an area of great potential interest. By analogy to the tonic inhibitory influence of vagus nerve activity on heart rate, depressed vagus nerve activity causes increased heart rate. Heart rate variability (HRV), one method used to quantify the strength of vagus nerve signaling, has been standardized and applied in numerous studies (Sloan et al., 2007a). These clinical results reveal a significant correlation between depressed vagus nerve activity and increased morbidity and mortality in nonresolving inflammatory diseases. For example, mortality rate in severe sepsis was 60% in those patients with decreased vagus nerve activity at admission to hospital, as compared with 0% mortality in subjects with higher vagus nerve activity (Pontet et al., 2003). Trauma patients with vagotomy had significantly increased mortality and septicemia as compared with a cohort of injured control patients matched for age, sex, co-morbidities, concurrent splenectomy, and other factors (Peterson et al., 2012). Numerous studies of HRV in rheumatoid arthritis revealed significantly reduced vagus nerve activity in patients as compared with controls (Evrengül et al., 2004; Goldstein et al., 2007). These clinical studies have not established a causal relationship between impaired vagus nerve signaling and disease, but this hypothesis has been proven in numerous preclinical animal studies. In the future it should be possible to address causality in prospective studies of vagus nerve modulation in humans (Table 1). An intriguing possibility is that vagus nerve deficiencies might be reversed by vagus nerve stimulation, by administration of α7 nAChR agonists, or by physiological methods that enhance vagus nerve activity, including aerobic exercise, acupuncture, meditation, music therapy, and biofeedback training (Table 1). Clinical trials of an implanted vagus nerve stimulator in rheumatoid arthritis are in progress, and other indications may be studied in the future. Table 1. Correlation between human activities/conditions and vagus nerve function. Activity/disease Vagus nerve function Reference Aerobic exercise Increase Sandercock et al., 2005; Jae et al., 2009; Earnest et al., 2012 Meditation Increase Peng et al., 2004 Acupuncture Increase Haker et al., 2000; Lee et al., 2011; Biofeedback training Increase Cowan et al., 1990; Nolan et al., 2005 Relaxation training Increase Sakakibara et al., 1994; Terathongkum and Pickler, 2004 Diet-supplemented fish oil or olive oil Increase Christensen et al., 1999; Holguin et al., 2005; Berbert et al., 2005 Sepsis Depressed function coupled to impaired survival Pontet et al., 2003; Barnaby et al., 2002; Kessler et al., 2006 Acute myocardial infarction Depressed function coupled to impaired survival Lanza et al., 1998, 2006 Cardiovascular disease Decrease Villareal et al., 2002 Rheumatoid arthritis, inflammatory bowel disease, SLE, sarcoidosis Decrease Lindgren et al., 1993; Stein et al., 1996; Laversuch et al., 1997; Evrengül et al., 2004 Head trauma Decrease Biswas et al., 2000; Su et al., 2005 Depression Decrease Kemp et al., 2010; Obesity Decrease Minami et al., 1999; Akehi et al., 2001; Facchini et al., 2003 Aging Decrease Zulfiqar et al., 2010 Exercise gateway reflex Neural circuits modulate adaptive immune responses. For example, during the earliest stages of experimental allergic encephalomyelitis, the murine model of human multiple sclerosis (MS), CD4+ T cells primed to attack myelinated neurons cross the blood–brain barrier in a specific anatomical location, entering the spinal cord at the level of the fifth lumbar vertebrae (Fig. 3; Arima et al., 2012). The dorsal blood vessels in this region express CCL20, which is up-regulated by neural signals in response to sensory neuron activity from the soleus muscles. Thus, suspending the mice from their tail to eliminate gravity-dependent activation of the sensory neurons significantly reduced chemokine expression at that specific lumbar level and prevented the entry of pathogenic T cells into the spinal column (Arima et al., 2012). Contraction of other muscle groups was associated with up-regulation of CCL20 at other anatomical locations, a finding that is consistent with the somatotopic organization and development of neural circuitry in the nervous system. Figure 3. Gateway reflex. Neural signals arising from soleus muscle contractions travel to the brain stem, and then descend into the sympathetic chain to the lumbar 5 level. This regulates the activity of adrenergic neurons that modulate the expression of CCL20 by endothelial cells, providing a crucial control mechanism that gates the entry of pathogenic T cells into the CNS. The muscle contraction–dependent reflex circuit that gates the entry of pathogenic T cells has several components, including the sensory neuron that relays afferent signals to the brain stem, cholinergic efferent neurons that descend from the brain stem in the sympathetic chain, and adrenergic neurons that deliver the terminal signal to the endothelial cell (Tracey, 2012). A similar circuit, termed the “exercise pressor reflex,” is activated during exercise by stimulation of mechanoreceptors and metabolically sensitive chemo-receptors in skeletal muscle (Kaufman and Hayes, 2002). Arrival at the brain stem of sensory input from muscles increases the activity of cholinergic neurons descending in the sympathetic chain. Because adrenergic neurons project to endothelial cells in numerous anatomical regions that can become inflamed, additional neural reflexes may modulate the onset of immunity and inflammation resolution at these other locations. For example, chronic cardiovascular fitness is associated with enhanced vagus nerve activity and decreases in TNF, IL-6, and C reactive protein, in agreement with the reduced metainflammation underlying atherogenesis in blood vessels. The paradigm that exercise can influence trafficking of inflammatory cells to discrete anatomical regions and reduce inflammatory burden in vasculature is particularly compelling (Sloan et al., 2007b; Thayer and Fischer, 2009; Wilund et al., 2009). Neural circuits in antibody responses Recent evidence revealed neural mechanisms that regulate B cell trafficking during maturation into antibody-secreting cells. The antibody response to Streptococcus pneumonia, which is T cell independent, is initiated by the appearance of phosphorylcholine in the spleen and culminates in the accumulation of antibody-secreting cells in the red pulp. These cells release antibodies into the splenic venous circulation. Electrical stimulation of the vagus nerve, or administration of nicotine, significantly impaired the migration of B cells, such that they accumulated in the marginal zone (Mina-Osorio et al., 2012). Moreover, electrical stimulation of the vagus nerve caused B cells, neutrophils, monocytes, and dendritic cells to accumulate in the marginal zone, rather than travel to the red pulp, as compared with unstimulated controls (Fig. 4). The net effect of this neural regulation is that antibody titers to specific antigenic challenge were significantly reduced. These findings have important implications, because prior studies of neural interactions with spleen lymphocytes in vivo have not used nerve stimulation to address mechanisms of immunity. It should now be possible to study these mechanisms in the context of specific reflex circuits that are activated by antigens and the innate immune response to invasion. The resultant efferent reflex signals regulate B cell trafficking and influence the nature of the adaptive immune response. Figure 4. Neural influence on B cell trafficking and antibody secretion. (A) Stimulation of vagus nerve signals stimulates the adrenergic splenic nerve. This leads to accumulation of CD11+ B cells in the marginal zone and decreased antibody production. (B) In the setting of diminished signaling from the vagus nerve to splenic nerve, antibody-secreting CD11b+ cells traverse the marginal zone and enter the red pulp, where they release antibodies into the circulation. Dietary antiinflammatory reflex The gut is richly innervated by cholinergic and adrenergic efferent neurons, and its sensory neurons deliver nearly continuous information to the nervous system. Mechanoreceptors are activated by bowel distention, and chemosensitive receptors are activated by bowel contents. Neither the commensal flora of the bowel nor dietary contents elicit significant activation of immune responses. Recent evidence indicates that neural signals activated by the consumption of dietary fat activate the inflammatory reflex. Specifically, dietary fat ingestion stimulates signaling through cholecystokinin (CCK) receptors, and these signals are relayed to the CNS (Luyer et al., 2005). The arrival of these incoming signals activates efferent vagus nerve signals, which inhibit the production of TNF and IL-6 in response to endotoxin or hemorrhagic shock. Administration of pharmacological antagonists of α7 nAChR or of CCK, or transection of the vagus nerve, abrogated the protective effect of high-fat nutrition. The potential implications of this nutrition-activated pathway may extend to conserved hyporesponsiveness to dietary antigens, and to the well known influence of nutritional content on innate immune responses (Tracey, 2005). Clinical studies of vagus nerve signaling indicate that dietary consumption of fish oil significantly enhances the basal vagus nerve activity, which has been proposed as an antiinflammatory mechanism to enhance resolution of inflammation (Christensen et al., 1999; Berbert et al., 2005; Holguin et al., 2005). Immunosuppressive stroke reflex Pneumonia and other infections are a major cause of morbidity and mortality after cerebral infarction (also called stroke). It has been suggested that stroke survivors are “immunosupppressed,” but until recently the underlying mechanisms were unknown. Two studies shed light on the neural circuits that contribute to immunosuppression after stroke, with important therapeutic possibilities. In an animal model of stroke, surviving mice exhibit significantly increased susceptibility to spontaneous bacterial sepsis and pneumonia (Prass et al., 2003). This occurred in association with extensive lymphocyte apoptosis, and a distinct shift in cytokine production from a T helper cell type 1 (Th1) to Th2 profile. The risk of bacterial infection was significantly reduced by transfer of WT, but not IFN-γ-deficient, T and natural killer cells on the first day after stroke, or by administration of propranolol to inhibit adrenergic signaling (Prass et al., 2003). Thus, an adrenergic-mediated defect in lymphocyte activation induces the immunosuppression that increases susceptibility to bacterial infection after stroke. Quite recently, adrenergic neurons projecting into the liver, which regulate hepatic invariant natural killer T (iNKT) cells, were implicated in promoting systemic immunosuppression after stroke (Wong et al., 2011). The mechanism was revealed by depleting hepatic adrenergic nerve terminals, and pharmacologically blockading β-adrenergic receptors with propranolol; both interventions significantly modulated iNKT cytokine production and reduced immunosuppression, bacterial infection rates, and mortality. These measures failed to protect mice that were deficient in iNKT cells, and direct administration of norepinephrine into the liver of WT mice worsened the immunosuppression and bacterial infection rates. Thus, it appears that iNKT mediated immunosuppression after stroke is regulated by the adrenergic neural circuit and shifts cytokine production from a Th1 to Th2 profile. It is plausible to consider whether neuromodulation to diminish signals to the liver, or pharmacological agents that act on these pathways, can prevent bacterial infection after stroke. The implications of these results may well extend beyond the phenomenon of cerebral infarction, to other CNS lesions associated with immunosuppression, including head trauma, Alzheimer’s and other neurodegenerative diseases, and severe sepsis survivors. Neural circuits in cytokine-mediated muscle wasting Sensory neurons express cytokine receptors (e.g., type I and type II TNF receptors and IL-1 receptors) and Toll like receptors. Activation of IL-1 receptors in the brain is sufficient to accelerate catabolism in skeletal muscle (Braun et al., 2011). Adrenalectomy prevented the expression of a distinct gene set in skeletal muscle of animals with increased brain IL-1 levels, indicating that signaling pathways initiated by inflammatory mediators in the brain contribute to peripheral muscle wasting. Evidence that elevated levels of TNF in brain accelerate skeletal muscle breakdown was obtained in mice that received brain tumors genetically engineered to secrete TNF (Tracey et al., 1990). Compared with animals bearing leg tumors with comparable serum TNF levels, the rate of skeletal muscle protein loss was significantly higher in animals with brain tumors expressing significantly higher levels of intracerebral TNF. Together, these results raise the intriguing possibility that neural circuits, in part by signaling through the hypothalamic-pituitary axis, occupy a critical role in the development of muscle wasting that is ubiquitous in chronic inflammatory diseases. TNF-mediated neural circuits in arthritis Cytokine mediated neural circuits that drive inflammation have been described in adjuvant arthritis. Unilateral antigen-induced arthritis in the rat knee induced macrophage infiltration in the lumbar, but not thoracic dorsal root ganglions, and enhanced expression of vascular cell adhesion molecule-1 (VCAM-1) in vessels of the lumbar ganglions (Segond von Banchet et al., 2009). Administration of anti-TNF antibodies reduced both VCAM-1 expression and macrophage infiltration, and significantly reduced the pain threshold (measured by mechanical hyperalgesia) in the affected joint and the unaffected contralateral knee. Intrathecal administration of anti-TNF significantly attenuated the severity of arthritis and reduced the signaling through adrenergic neurons (Boettger et al., 2008). Thus, TNF can drive neural signals that modulate inflammation in a specific anatomical region. Clinical experience in treating rheumatoid arthritis patients with anti-TNF reveals that patients frequently receive significant pain relief within a few hours or days after first dosing, a time frame too early to be explained by inflammation resolution. Functional MRI focusing on blood oxygen level-dependent (BOLD) signals in brain regions corresponding to metacarpal phalangeal joints, pain perception, and the processing of body sensations and painful emotions (Hess et al., 2011) revealed that activity in these regions was significantly reduced within 24 h after the administration of anti-TNF, even though composite inflammation scores that included levels of C-reactive protein did not improve for at least 24 h. Strikingly, similar findings were obtained in TNF transgenic mice with arthritis, in which anti-TNF mediated a rapid improvement of mechanical hyperalgesia in a von Frey filament test; this was associated with significantly attenuated spreading of BOLD signals in the somatosensory cortex (Hess et al., 2011). It therefore appears that TNF activates neural signals to the CNS, which converge on pain circuit neurons, and that these circuits are interdependent or perhaps overlapping with neural circuits that influence inflammation resolution in the affected joints (Diamond and Tracey, 2011). Neural development Neural circuits that regulate immunity evolved in response to products of immunity to infection and injury, and are directly relevant to the developing fetal brain. Autoantibodies against double-stranded DNA, found in a significant percentage of women with autoimmune diseases, also bind the N-methyl-d-aspartate (NMDA) receptor with functional consequence (DeGiorgio et al., 2001). In a murine model of systemic lupus erythematosus, high titers of anti-NMDA receptor autoantibodies in pregnant dams entered the fetal brain resulting in abnormal development of neural circuitry and offspring that were cognitively impaired (Faust et al., 2010). These autoantibodies were functional, because they exerted agonist activity by specifically binding to the extracellular domains of the NR2A and NR2B subunits of the glutamatergic NMDA receptor. Direct administration of these antibodies into mouse hippocampus caused significant neuronal death. Moreover, expression of these antibodies in pregnant dams caused apoptosis of NR2A-expressing neurons within the fetal brainstem and loss of viability of female pups (Wang et al., 2012). This maternal antibody-dependent neural mechanism of fetal death is consistent with the observed live birth sex ratio in SLE pregnancy. The implications of this work provide a direct link through which antibodies sculpt neuronal circuitry in the developing brain (DeGiorgio et al., 2001; Kowal et al., 2004; Lapteva et al., 2006; Faust et al., 2010; Wang et al., 2012). Microbial colonization of the gut may also influence neural development. Germ-free animals show increased motor activity and reduced anxiety compared with mice harboring a normal gut microbiota (Heijtz et al., 2011). These findings correlate with gene expression patterns in brain regions that regulate motor function and anxiety. Reconstituting the gut microbiome in germ-free mice reversed the behavioral and gene expression patterns, revealing that microbial colonization mediates signals to the CNS that influence the development and function of neuronal circuits. It is likely that humoral and neural signaling arising from the immune system in response to gut microbiota influences brain development (Diamond et al., 2011). Brain development and neuroplasticity continue after birth, as experience molds the efficiency of signals through basic CNS circuits formed by extensive networks of synaptic connections. During early life there is a degree of plasticity that shapes these pathways underlying behavior and homeostatic reflex responses. Cytokine levels can increase significantly in the brain in response to infection or injury, or by entering the brain during periods of stress-induced opening of the blood–brain barrier. Elevated brain TNF levels occur during brain inflammation, ischemia, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and multiple sclerosis. In addition to the behavioral effects on physiological and metabolic homeostasis noted above, increased brain levels of TNF and IL-1 can significantly modify neuronal activity underlying the function of brain networks. TNF modulates the neuronal expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and NMDA receptors. TNF also modulates homeostatic synaptic scaling, a neurophysiological mechanism that maintains optimal neural network function and stability (Stellwagen and Malinka, 2006). By modulating NMDA and AMPA receptor expression, TNF adjusts the strength of neuronal synapses in response to long-lived changes in electrical activity. IL-1β and HMGB1 are also increased during brain inflammation or injury, and have been implicated in modulating NMDA receptor activity during neurodegeneration, ischemia, and seizure disorders. Future directions Neuroscience and immunology are now armed with the new paradigm that specific steps in immunity are modulated by discrete neural circuits that signal through defined molecular mechanisms. Accordingly, it is reasonable to propose that additional neural pathways will be identified and mapped. This can be accomplished from either a top-down or a bottom-up approach, because reflexes require both afferent signals from the interaction of the immune system with the nervous system, and efferent messages to the immune system from the nervous system. Mapping such circuits anatomically and functionally is likely to reveal important information about the network of information sharing between two elaborate, highly coevolved systems of defense and memory.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The neutrophil in chronic obstructive pulmonary disease.

              Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and has few effective therapies. It is characterized by anomalous and persistent inflammation, both local and systemic. Neutrophilic inflammation predominates in the COPD airway wall and lumen, but, despite the presence of abundant innate immune cells, the progressive clinical course of the disease is punctuated by recurrent infection-driven exacerbations. An extensive body of evidence (from cell culture to murine models and finally to the susceptibility of human patients with α1-antitrypsin deficiency to develop COPD) implicates neutrophil elastase and other neutrophil-derived proteases as key mediators of the tissue damage and relentless decline in lung function that occurs in this condition. In addition to the well recognized role of cytokines in modulating neutrophil function and survival, it has recently become apparent that hypoxia can influence neutrophil function, with impaired killing of pathogenic bacteria, enhanced release of proteases, and delayed apoptosis. This destructive neutrophil phenotype is predicted to be highly detrimental in the setting of the COPD microenvironment.
                Bookmark

                Author and article information

                Journal
                Int J Chron Obstruct Pulmon Dis
                Int J Chron Obstruct Pulmon Dis
                International Journal of COPD
                International Journal of Chronic Obstructive Pulmonary Disease
                Dove Medical Press
                1176-9106
                1178-2005
                2017
                28 July 2017
                : 12
                : 2207-2220
                Affiliations
                [1 ]First Critical Care Department, Pulmonary Unit, National and Kapodistrian University of Athens Medical School, Evangelismos General Hospital
                [2 ]George P. Livanos and Marianthi Simou Laboratories, Thorax Foundation
                [3 ]Department of Pathology, Evangelismos General Hospital, Athens, Greece
                [4 ]Boehringer Ingelheim Pharma GmbH & Co. KG Div. Research Germany, Biberach, Germany
                Author notes
                Correspondence: Theodoros Vassilakopoulos, First Critical Care Department, Pulmonary Unit, National and Kapodistrian University of Athens Medical School, Evangelismos General Hospital, 45-47 Ispilandou Street, 10676 Athens, Greece, Tel +30 21 3204 1952, Fax +30 21 0724 4941, Email tvassil@ 123456med.uoa.gr
                Article
                copd-12-2207
                10.2147/COPD.S137587
                5546183
                © 2017 Toumpanakis et al. This work is published and licensed by Dove Medical Press Limited

                The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

                Categories
                Original Research

                Respiratory medicine

                resistive breathing, inflammation, tiotropium bromide

                Comments

                Comment on this article